Gemcitabine Direct Electrochemical Detection from Pharmaceutical Formulations Using a Boron-Doped Diamond Electrode

The development of fast and easy-to-use methods for gemcitabine detection is of great interest for pharmaceutical formulation control in both research laboratories and hospitals. In this study, we report a simple, fast and direct electrochemical method for gemcitabine detection using a boron-doped diamond electrode. The electrochemical oxidation of gemcitabine on a boron-doped diamond electrode was found to be irreversible in differential pulse voltammetry, and scan rate influence studies demonstrated that the process is diffusion-controlled. The influence of the pH and supporting electrolytes were also tested, and the optimized differential pulse voltammetry method was linear in the range of 2.5–50 μg/mL, with a detection limit of 0.85 μg/mL in phosphate-buffered saline (pH 7.4; 0.1 M). An amperometric method was also optimized for gemcitabine detection. The linear range of the method was 0.5–65 μg/mL in phosphate-buffered saline of pH 7.4 as well as pH 5.5, the limit of detection being 0.15 μg/mL. The optimized differential pulse voltammetry and amperometric detection strategies were successfully applied to pharmaceutical formulations, and the results were compared to those obtained by high-performance liquid chromatography and UV-Vis spectrophotometry with good correlations.

[1]  K. Ohyama,et al.  Determination of Gemcitabine in Plasma of Bladder Cancer Patients by Hydrophilic Interaction Chromatography with Ultraviolet Detection. , 2020, Journal of chromatographic science.

[2]  S. Krishnan,et al.  Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells. , 2020, Journal of drug delivery science and technology.

[3]  A. Kermanpur,et al.  Electrochemical molecularly bioimprinted siloxane biosensor on the basis of core/shell silver nanoparticles/EGFR exon 21 L858R point mutant gene/siloxane film for ultra-sensing of Gemcitabine as a lung cancer chemotherapy medication. , 2019, Biosensors & bioelectronics.

[4]  A. Borowsky,et al.  Tumor-specific delivery of gemcitabine with activatable liposomes. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Y. Yeo,et al.  Development of Liposomal Gemcitabine with High Drug Loading Capacity. , 2019, Molecular pharmaceutics.

[6]  Jf Yang,et al.  Concentration changes in gemcitabine and its metabolites after hyperthermia in pancreatic cancer cells assessed using RP-HPLC , 2019, Cellular & Molecular Biology Letters.

[7]  Wei Zhang,et al.  Boron-doped diamond: current progress and challenges in view of electroanalytical applications , 2019, Analytical Methods.

[8]  M. Locatelli,et al.  Simultaneous quantification of Gemcitabine and Irinotecan hydrochloride in rat plasma by using high performance liquid chromatography‐diode array detector , 2018, Journal of pharmaceutical and biomedical analysis.

[9]  G. Esendagli,et al.  Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. , 2017, International journal of pharmaceutics.

[10]  Gözde Aydoğdu Tığ,et al.  Electrochemical DNA biosensor based on poly(2,6-pyridinedicarboxylic acid) modified glassy carbon electrode for the determination of anticancer drug gemcitabine. , 2016, Talanta.

[11]  E. Giovannetti,et al.  Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective , 2016, Cancer Chemotherapy and Pharmacology.

[12]  Keerti Jain,et al.  Controlled delivery of Gemcitabine Hydrochloride using mannosylated poly(propyleneimine) dendrimers , 2015, Journal of Nanoparticle Research.

[13]  N. Jaffrezic‐Renault,et al.  Anticancer drug detection using a highly sensitive molecularly imprinted electrochemical sensor based on an electropolymerized microporous metal organic framework. , 2015, Talanta.

[14]  A. Shakya,et al.  Stability-Indicating HPLC Determination of Gemcitabine in Pharmaceutical Formulations , 2015, International journal of analytical chemistry.

[15]  K. M. Naik,et al.  Electro-oxidation and determination of gemcitabine hydrochloride, an anticancer drug at gold electrode , 2013 .

[16]  Nagappa L. Teradal,et al.  Electrochemical investigations of an anticancer drug in the presence of sodium dodecyl sulfate as an enhancing agent at carbon paste electrode , 2012, Journal of Applied Electrochemistry.

[17]  Bhoomika R. Mistry,et al.  Analytical detection and method development of anticancer drug Gemcitabine HCl using gold nanoparticles. , 2012, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[18]  S. S. Kalanur,et al.  Electrochemical studies and spectroscopic investigations on the interaction of an anticancer drug with DNA and their analytical applications , 2009 .

[19]  F. Cappuzzo,et al.  Role of gemcitabine in cancer therapy. , 2005, Future oncology.

[20]  K. Goa,et al.  Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. , 1997, Drugs.